Cochlear
- Short interest
- 1.88%
- −0.41 pp 30d
- as of 9 Oct 2026
- Reported shorts
- 1.2M
- Shares on issue
- 65.399M
Cochlear (COH) Short Interest
Cochlear (ASX:COH) had 1.88% of shares reported as short positions as of 9 Oct 2026, representing 1,226,856 shares. Cochlear operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Cochlear
Cochlear is a leading global provider of implantable hearing solutions, known for its innovative cochlear implant systems. The company holds a strong market position due to its advanced technology and commitment to improving hearing outcomes. Cochlear's unique value lies in its continuous investment in research and development, ensuring cutting-edge solutions for hearing loss.
Company profile →Cochlear (ASX:COH) has 1.88% of its shares on issue reported as short positions as of 9 Oct 2026, or about 1,226,856 shares. Over the past 30 days that figure has fallen 0.41 percentage points, and over 90 days it has fallen 8.07 percentage points. Its highest recorded short interest was 18.50% in July 2014. COH is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads COH today
- Zanger BreakoutWatchScore 33rank 460 of 1942
- CAN SLIMWatchScore 10rank 1037 of 1541
- Minervini Trend TemplateWatchScore 16rank 1052 of 1716
- Crowded-Short BreakoutWatchScore 20rank 316 of 1500
- Quality compoundersWatchScore 46rank 161 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
COH fundamentals
In the year to 30 Jun 2026, Cochlear (ASX:COH) recorded revenue of A$2.3B and net profit after tax of A$147.3M. A year earlier it recorded revenue of A$2.3B and net profit after tax of A$388.9M. Year-on-year growth: revenue +0.2% (FY), EPS −62.1% (TTM). Net margin 6.3%, return on equity 8.0% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest COH news
All news- Notification of cessation of securities - COH
asx · 13 Oct 2026
- Notification regarding unquoted securities - COH
asx · 13 Oct 2026
- Ceasing to be a substantial holder
asx · 11 Oct 2026
Company details
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss COH
Start a research thread or post the first pulse update